|
Market Closed -
Nasdaq
16:00:00 2026-05-08 EDT
|
5-day change
|
1st Jan Change
|
|
47.90 USD
|
-0.60%
|
|
-0.13%
|
-29.97%
|
|
04-10 |
DocuSign Shares Fall After Citigroup Downgrade
|
MT
| |
04-10 |
Citigroup Downgrades DocuSign to Neutral From Buy, Adjusts PT to $50 From $99
|
MT
| |
03-31 |
DocuSign Faces Transition Year as Growth Inflection Remains Distant, BofA Says
|
MT
| |
03-18 |
Wedbush Cuts Price Target on DocuSign to $60 From $75 Highlighting Weak Multiples, Maintains Neutral Rating
|
MT
| |
03-18 |
DocuSign Posts Solid Fiscal Q4 Results, Healthy Full-Year Outlook, Wedbush Says
|
MT
| |
03-18 |
DocuSign's Fiscal Q4 Beat Street Consensus, Fiscal 2027 Guidance In-Line, RBC Says
|
MT
| |
03-18 |
DocuSign's IAM Platform Appears Defensive Rather Than Path to Growth, Morgan Stanley Says
|
MT
| |
03-18 |
UBS Adjusts Price Target on DocuSign to $54 From $75, Maintains Neutral Rating
|
MT
| |
03-18 |
Wedbush Adjusts Price Target on DocuSign to $60 From $75, Maintains Neutral Rating
|
MT
| |
03-18 |
RBC Cuts Price Target on DocuSign to $55 From $70, Keeps Sector Perform Rating
|
MT
| |
03-18 |
Morgan Stanley Cuts Price Target on DocuSign to $69 From $90, Keeps Equalweight Rating
|
MT
| |
02-23 |
DocuSign Shares Fall After Downgrade From Jefferies
|
MT
| |
02-23 |
Jefferies Downgrades DocuSign to Hold From Buy, Adjusts Price Target to $45 From $105
|
MT
| |
01-05 |
RBC Cuts Price Target on DocuSign to $70 From $95, Keeps Sector Perform Rating
|
MT
| |
12-17 |
BTIG Initiates DocuSign at Buy With $88 Price Target
|
MT
| |
12-05 |
DocuSign's Lack of Q4 Outlook Lift Disappoints, UBS Says
|
MT
| |
12-05 |
UBS Adjusts DocuSign Price Target to $75 From $85, Maintains Neutral Rating
|
MT
| |
12-05 |
Wedbush Adjusts DocuSign Price Target to $75 From $85, Maintains Neutral Rating
|
MT
| |
25-09-05 |
RBC Raises Price Target on DocuSign to $95 From $90, Keeps Sector Perform Rating
|
MT
| |
25-06-13 |
Wells Fargo Upgrades DocuSign to Equalweight From Underweight, Price Target is $80
|
MT
| |
25-06-06 |
DocuSign's Fiscal Q1 Billings Miss, Lower Billings Guidance Reflect Focus on Improving IAM Strategy, Wedbush Says
|
MT
| |
25-06-06 |
UBS Lowers Price Target on DocuSign to $80 From $85, Maintains Neutral Rating
|
MT
| |
25-06-06 |
Wedbush Cuts Price Target on DocuSign to $85 From $100, Keeps Neutral Rating
|
MT
| |
25-06-06 |
Morgan Stanley Cuts Price Target on DocuSign to $86 From $92, Keeps Equalweight Rating
|
MT
| |
25-04-17 |
UBS Adjusts Price Target on DocuSign to $85 From $90, Keeps Neutral Rating
|
MT
|
No results for this search
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|